Smartleaf Asset Management
ARKG icon

Smartleaf Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Smartleaf Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.47K Hold
27
– – ﹤0.01% 3116
2026
Q2 		$1.14K Hold
27
– – ﹤0.01% 3079
2026
Q1 		$670 Sell
27
-365
-93% -$10.7K ﹤0.01% 3177
2025
Q4 		$11.4K Buy
+392
New +$11.8K ﹤0.01% 2335

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
Florin Court Capital
Florin Court Capital London, United Kingdom $97M AUM 40.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
NTV Asset Management
NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Smartleaf Asset Management's ARKG Position: Q3 2026 in Review

Smartleaf Asset Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2026 at 27 shares worth $1.47K. The position accounts for ﹤0.01% of the portfolio, ranked #3116.

Smartleaf Asset Management first reported a position in ARKG in Q4 2025 and has held it in 4 quarters since. The position peaked at $11.4K in Q4 2025. 220 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Smartleaf Asset Management held 27 shares of ARK Genomic Revolution ETF worth $1.47K as of Q3 2026.
  • Smartleaf Asset Management left its ARK Genomic Revolution ETF share count unchanged in Q3 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3116 holding.
  • Smartleaf Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2025 and has held it in 4 quarters since.
  • Smartleaf Asset Management's ARK Genomic Revolution ETF position peaked at $11.4K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.